SCHEMBL21364015

SCHEMBL21364015

C=CC(=O)Nc1cc(Nc2ncc(C3=CCOCC3)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N1CCC(N2CCN(C)CC2)CC1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALK Q9UM73 19/20 0.65
▸ EGFR P00533 8/20 0.65
▸ INSR P06213 5/20 0.55
▸ EML4 Q9HC35 5/20 0.55
▸ ROS1 P08922 3/20 0.55
▸ FER P16591 3/20 0.55
▸ LTK P29376 3/20 0.55
▸ PTK2 Q05397 3/20 0.55
▸ BTK Q06187 3/20 0.55
▸ TNK2 Q07912 3/20 0.55
▸ SLK Q9H2G2 3/20 0.55
▸ IGF1R P08069 3/20 0.55
▸ BMPR1B O00238 2/20 0.55
▸ PLK4 O00444 2/20 0.55
▸ GAK O14976 2/20 0.55
▸ ERN1 O75460 2/20 0.55
▸ STK10 O94804 2/20 0.55
▸ ABL1 P00519 2/20 0.55
▸ LCK P06239 2/20 0.55
▸ FYN P06241 2/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19027406 0.87 ALK (0.73) ALKEGFRINSREML4ROS1
SCHEMBL19027412 0.87 ALK (0.85) ALKEGFRINSREML4ROS1
SCHEMBL21363944 0.83 EGFR (0.78) ALKEGFRINSREML4ROS1
SCHEMBL19027794 0.81 ALK (0.95) ALKEGFRINSREML4ROS1
SCHEMBL19027796 0.80 ALK (0.81) ALKEGFRINSREML4ROS1
Trifluoroacetic Acid SCHEMBL21358354 0.79 EGFR (0.72) ALKEGFRINSREML4ROS1
SCHEMBL19027384 0.79 ALK (0.82) ALKEGFRINSREML4ROS1
SCHEMBL19027868 0.79 ALK (0.63) ALKEGFRINSREML4ROS1
SCHEMBL19027749 0.79 ALK (1.00) ALKEGFRINSREML4ROS1
SCHEMBL19027755 0.79 ALK (0.73) ALKEGFRINSREML4ROS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019177375-A1 2, 4, 5-SUBSTITUTED PYRIMIDINE DERIVATIVES, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER COMPRISING SAME AS ACTIVE INGREDIENT 포로노이바이오 주식회사 2019-09-19 — — WO disclosed
Send feedback